Medical Informatics World’s Inaugural
Sensors for Medical Applications
Sensor Design, Engineering & Manufacturing for Integrated Healthcare Devices
Emerging technological innovations enabled by next generation sensors will define the landscape for the future commercialization of life changing medical devices. The exponential growth of the global sensors market and the demand for next generation integrated systems is expected to reach $18 billion by 2018. Low cost materials and advances in nano and micro fabrication techniques within the manufacturing process have led to significant increases in the commercialization of sensors for healthcare applications.
Cambridge Healthtech Institute and Clinical Informatics News’ Sensors for Medical Applications taking place May 22-23, 2017 at the Renaissance Waterfront Hotel in Boston, MA, will examine the latest advancements in research and integration and will provide attendees with the state-of-the-art in sensors development for healthcare.
Final Agenda
Monday, May 22
Day 1 | Day 2 | Download Brochure
7:00 am Registration and Morning Coffee
8:00 am MONDAY MORNING KEYNOTES:
John Mattison, M.D., Assistant Medical Director, CMIO, CHIO, National and Regional Leadership, Kaiser Permanente
Andrea Ippolito, VA Innovators Lead, Department of Veterans Affairs Center for Innovation
Saurabha Bhatnagar, M.D., Innovation Specialist, Medical Director TBI/Polytrauma, Harvard Medical School
Patrick McIntyre, Senior Vice President, Health Care Analytics, Anthem, Inc.
David Shein, M.D., Medical Director, The Mount Auburn Cambridge Independent Practice Association (MACIPA)
View Details
10:10 Coffee Break in the Exhibit Hall with Poster Viewing
10:55 Chairperson’s Remarks
Thomas Dawidczyk, Ph.D., Analyst, Lux Research’s Wearable Electronics Intelligence Service
11:00 Mobile Sensors Reducing Blind Spots in Clinical Research and Beyond
Christian Gossens, Ph.D., Global Head Early Development Workflows, Roche Pharmaceutical Research and Early Development
As soon as patients leave the clinic, their disease progression is often very difficult to follow. This is a challenge for clinical research and can even result in sub-optimal treatment. But objective, automated and high frequency measures of disease progression were hard to come by. Now, mobile sensors are readily available to bring light to these blind spots. This talk will highlight the latest progress in using mobile sensors in clinical research at Roche.
11:30 Fiber- and Fabric-Based Devices for Energy Conversion and Sensing Applications
Max Shtein, Ph.D., Associate Professor, Materials Science and Engineering, University of Michigan
Here we review advances in fiber- and fabric-based sensing and energy conversion devices as well as emerging materials which can serve as building blocks for a revolutionary, new class of electronics. We will use the analysis to propose novel device and application concepts, share thoughts on a development roadmap for this new platform, and outline the capabilities and interests of researchers at the University of Michigan as a member of the Advanced Functional Fabrics of America (AFFOA) Innovative Manufacturing Institute.
12:00 pm Enabling (Microscale) Measurement Technology for Biomedical Research
Steve Semancik, Ph.D., Physicist/Project Leader in the Biomolecular Measurement Division, National Institute of Standards and Technology (NIST)
New fabrication methods for creating nanoengineered surfaces and functional microdevices provide opportunities for developing biosensors with enhanced characterization and analytical capabilities. This presentation will describe how such materials and devices are employed in probing and signal-generation schemes for immobilized biomolecular species, on both photonic and electrochemical platforms. Implications for future medical diagnostic screening and drug discovery applications will be discussed.
12:30 Sponsored Presentation (Opportunity Available)
12:45 Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own
1:30 Session Break
2:05 Chairperson’s Remarks
Steve Semancik, Ph.D., Physicist/Project Leader in the Biomolecular Measurement Division, National Institute of Standards and Technology (NIST)
2:10 Making Sense of Sensors in Clinical Trials
Martin Karpefors, Informatics Science Director, Advanced Analytics Centre, AstraZeneca
The use of sensors in clinical trials offers both promise, and challenge. We see operational advantages through increased patient engagement, better compliance and fewer visits to study centers, yet concerns about reliability, privacy and regulatory acceptance remain. Here, we outline and exemplify these experiences of novel multi-variant analytics for utilizing (multi-)sensor data, through fascinating and sometimes frustrating examples of our experience to date.
2:40 Innovating for Billions with Computational Sensors
Pratik Shah, Ph.D., CO-PI and Research Scientist, MIT Media Lab, Massachusetts Institute of Technology
Will present recently published work describing the next-generation of computational sensing platforms based on optics, machine learning to image and quantify a variety of biomarkers linked to cancer and infectious diseases. Open hardware and software platforms to freely disseminate these sensors in two international locations have been setup. Offline and secure data acquisition, and mobile phone-based machine learning platforms are being developed to provide service to resource limited settings.
3:10 Sponsored Presentation (Opportunity Available)
3:40 Refreshment Break in the Exhibit Hall with Poster Viewing
4:10 pm Find Your Table and Meet Your Moderator
4:15 Interactive Breakout Discussion Groups
Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. To get the most out of this interactive session and format, please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea-sharing.
View Details
5:00 - 6:00 Welcome Reception in the Exhibit Hall with Poster Viewing
6:00 Close of Day
Tuesday, May 23
Day 1 | Day 2 | Download Brochure
7:30 am Registration and Morning Coffee
8:00 am TUESDAY MORNING KEYNOTES:
John Halamka, M.D., MS, CIO, Beth Israel Deaconess Medical Center
Maxine Mackintosh, Chair & Ph.D. Student, HealthTech Women UK & University College London
Trishan Panch, M.D., Co-Founder and CMO, Wellframe; Lecturer, MIT
View Details
10:10 Coffee Break in the Exhibit Hall with Poster Viewing
10:55 Chairperson’s Remarks
Christopher M. Hartshorn, Ph.D., Program Director, Center for Strategic Scientific Initiatives, National Cancer Institute, NIH
11:00 Ultra Low-Cost, High-Throughput Smartphone Optosensors for Mobile Point-of-Care Diagnostics
Lei Li, Ph.D., Assistant Professor, Mechanical and Materials Engineering, Washington State University
We will be presenting miniaturized ultra-low-cost, high-throughput smartphone optosensors for mobile point-of-care (MPOC) diagnostics that is exploring the use of colorimetric assays. We have validated our smartphone optosensors via measuring a type of human cancer biomarker and quantifying protein amounts. We envision that our platforms are appropriate for clinical diagnostics by clinicians in rural, remote or less-resource areas.
11:30 Bio-Inspired DNA Sensors: Applications in Medicine
Alexis Vallée-Bélisle, Assistant Professor, Chemistry, University of Montreal
All creatures, from bacteria to humans, monitor their environments in order to survive. They do so with biomolecular switches, made from RNA or proteins. In my talk, I will explain how we design and build these nanoswitches and show how a better understanding of natural biomolecular switches and their mechanisms of regulation (e.g. inhibition, activation, and cooperativity) significantly helps our efforts to build a more efficient sensing technology for sensing applications.
12:00 pm Wearable Transdermal Biosensors: Understanding the Chemical Self
Joshua Windmiller, Ph.D., CTO & Founder, Biolinq Technologies, Inc.
This talk highlights the development of a novel class of minimally-invasive electrochemical biosensors that facilitate the quantification of relevant metabolomic, electrolytic, hormonal, and neurochemical information in a continuous, real-time fashion.
12:30 Creating New Opportunities in Wearables from the Shift to Patient-Centric Care
Thomas Dawidczyk, Ph.D., Analyst, Lux Research’s Wearable Electronics Intelligence Service
Medical devices are migrating out of the hospital and integrating into patients’ daily lives. These sensing devices utilize smaller, cheaper, and more accessible sensors allowing more patient-centric solutions. Sensor technology is a major enabler of early diagnostics and preventative approaches, which is one of the current challenges facing the healthcare system. This presentation will address current and future market trends, focusing on strategies that can succeed in both the consumer and clinical markets.
12:45 Luncheon Presentation (Sponsorship Opportunity Available) or Enjoy Lunch on Your Own
1:30 Coffee and Dessert in the Exhibit Hall with Poster Viewing
2:00 Chairperson’s Remarks
Perena Gouma, Ph.D., Professor, Department of Materials Science and Engineering, University of Texas at Arlington
2:05 Enabling Wearable Sensor Technologies for Clinical Use
Christopher M. Hartshorn, Ph.D., Program Director, Center for Strategic Scientific Initiatives, National Cancer Institute, NIH
Real-time and continuous passive monitoring of patient/disease/therapeutic specific factors, outside of the clinic, will play a large role in medical care and measurement of the subtler aspects of disease in the near future. Multiple wearable sensor technologies exist currently and the next generations will offer more biological relevance. This presentation will be to highlight efforts at the NIH of which have or are soon to have emphasis on monitoring outside the clinic to offer a broader understanding of disease and to inform clinical decision-making.
2:35 Patient Connected Sensors for Remote Health Monitoring
Tony Zarola, Director, Healthcare, Analog Devices
As we move more and more towards remote health monitoring reliance on the information derived from patient connected sensors becomes more critical. The presentation will address how sensor ecosystem needs to evolve to effectively monitor the true health of the patient
3:05 Medical Grade Wearables for Mainstream Healthcare
Ravi Kuppuraj, Business Leader, Connected Sensing, Philips
Do medical grade wearables have a place in mainstream healthcare? In this session, we will explore and examine medical grade wearables and see how some of the most significant innovation in healthcare is happening in this space.
3:35 Diagnostic Breathalyzers and Wearable Gas Detectors Based on Selective Chemosensing
Perena Gouma, Ph.D., Professor, Department of Materials Science and Engineering, University of Texas at Arlington
In this talk, an overview is presented of my research through the past 10 years: from identifying the specific gas-metal oxide interactions that give rise to selective biomarker detection in a single breath exhale, to the development of prototype devices for asthma or diabetes monitoring. It will also be discussed how the monitoring of more than one biomarkers at a time may assist in the early detection of flu or other infections. Finally, applications of this technology to monitoring animal health and food quality will also be discussed.
4:05 Closing Remarks
5:00 - 7:00 Join Bio-IT World’s Grand Opening Reception in the Bio-IT World Exhibit Hall at the Seaport World Trade Center
Day 1 | Day 2 | Download Brochure